Salmonella Typhi, a specific serotype of Salmonella enterica, is responsible for causing typhoid fever, a systemic and potentially life-threatening illness. Typhoid fever is predominantly associated with contaminated food and water in regions with poor sanitation and hygiene. The bacteria invade the intestinal mucosa, enter the bloodstream, and disseminate to various organs, leading to systemic symptoms. Typhoid fever symptoms include prolonged fever, headache, abdominal pain, and a characteristic rose-colored rash. Without appropriate treatment, complications such as intestinal perforation can occur. Typhoid fever is a significant global health concern, particularly in areas with inadequate sanitation infrastructure. Preventive measures for Salmonella Typhi include vaccination, improvements in sanitation and hygiene, and the provision of safe drinking water. Antimicrobial therapy is crucial for the management of typhoid fever, but increasing antibiotic resistance poses a challenge to effective treatment. Ongoing research focuses on understanding the epidemiology of typhoid fever, developing new vaccines, and addressing antimicrobial resistance to enhance control and prevention strategies. Typhoid fever remains a serious public health issue, emphasizing the importance of comprehensive approaches to combat Salmonella infections on both the gastrointestinal and systemic levels.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain